By Ryan Bloom, Christina Loh, Ph.D., Grace Zheng Ph.D., and Sebastian CaliriRegulus Therapeutics (RGLS), whose focus is on targeting small regulatory RNAs called microRNAs, is a joint venture between two leading RNA therapeutics companies, Isis (ISIS) ...
[Published Seeking Alpha - May 06 2013]